Indian pharmaceutical stocks opened the session on April 28, 2026, with a mixed tone. The Nifty Pharma Index stood at 23,132.0, down 0.2% in early trade, while the broader S&P BSE Healthcare Index was flat at 44,677.94. The Nifty 50 traded near flat at 24,105.95, and the Sensex edged marginally lower at 77,265.41. Across the pharma space, gains and losses were spread relatively evenly in the opening half-hour.
The data below reflects early-session prices captured at around 9:31–9:35 AM IST.
Glenmark Pharma led early gainers with a near 1.8% rise on both exchanges. On the downside, Strides Pharma Science saw the sharpest fall, dropping over 2% on BSE in early trade.
Top Movers — Early Session
Complete Stock Price Table — April 28, 2026
| Company | BSE Price (₹) | BSE Chg | NSE Price (₹) | NSE Chg |
|---|---|---|---|---|
| Aarti Drugs | 380.90 | −0.12% | 380.90 | −0.24% |
| Ajanta Pharma | 2,797.95 | −0.29% | 2,791.10 | −0.57% |
| Alembic Pharma | 758.40 | −0.74% | 760.00 | −0.60% |
| Aurobindo Pharma | 1,415.55 | −0.15% | 1,417.30 | +0.04% |
| Biocon | 363.55 | +0.48% | 363.35 | +0.37% |
| Cipla | 1,318.90 | +0.13% | 1,319.00 | +0.14% |
| Divi’s Laboratories | 6,482.60 | +0.11% | 6,485.50 | +0.13% |
| Dr. Reddy’s Lab | 1,343.00 | +0.63% | 1,338.20 | +0.28% |
| Glenmark Pharma | 2,366.60 | +1.80% | 2,367.40 | +1.82% |
| Indoco Remedies | 210.00 | +1.52% | 209.90 | +0.44% |
| IPCA Labs | 1,546.55 | +0.59% | 1,546.00 | +0.30% |
| J.B. Chemicals | 2,057.45 | +0.47% | 2,055.90 | +0.41% |
| Lupin | 2,304.10 | −0.87% | 2,303.60 | −0.90% |
| Mankind Pharma | 2,246.05 | −0.88% | 2,246.70 | −0.97% |
| Natco Pharma | 1,098.50 | +0.77% | 1,098.90 | +0.83% |
| Orchid Pharma | 585.55 | +0.09% | 582.00 | −0.56% |
| Panacea Biotech | 375.10 | +1.56% | 376.00 | +1.94% |
| Strides Pharma Science | 1,074.30 | −2.12% | 1,079.40 | −1.74% |
| Sudeep Pharma | 682.55 | +0.46% | 682.95 | +0.57% |
| Sun Pharma | 1,729.45 | −0.25% | 1,730.60 | −0.17% |
| Torrent Pharma | 4,225.05 | +0.13% | 4,217.90 | −0.05% |
| Wockhardt | 1,421.00 | −1.38% | 1,419.80 | −1.23% |
| Zydus Lifesciences | 918.80 | −1.40% | 916.95 | −2.42% |
Sector Overview
The Nifty Pharma Index, which tracks major listed pharmaceutical companies on the NSE, was trading at 23,132.0, down 0.2% as of early session on April 28, 2026. This places the index in slightly negative territory to start the week, though the magnitude of the decline remained small at this point in the session.
The S&P BSE Healthcare Index was effectively unchanged at 44,677.94 — flat at the open — suggesting the broader healthcare space was neither under meaningful selling pressure nor seeing significant buying interest in early trade.
Among large-cap names, Sun Pharma — the sector’s biggest company by market capitalisation — was marginally lower, trading at ₹1,729.45 on BSE (down 0.25%). Cipla was a modest gainer at ₹1,318.90, up 0.13%. Dr. Reddy’s Laboratories was the notable outperformer among large caps, rising 0.63% on BSE to ₹1,343.
Lupin and Mankind Pharma were among the larger-cap decliners, both falling close to 0.9% on BSE. Zydus Lifesciences saw steeper losses, down 1.40% on BSE and 2.42% on NSE in the same window. Wockhardt declined 1.38% on BSE.
Notable Individual Moves
Glenmark Pharma was the standout gainer in the session, rising approximately 1.8% on both exchanges to trade at ₹2,366.60 (BSE) and ₹2,367.40 (NSE). No specific news catalyst was identifiable from the data provided.
Strides Pharma Science saw the sharpest decline in the group, falling 2.12% on BSE to ₹1,074.30 and 1.74% on NSE to ₹1,079.40. Panacea Biotech moved in the opposite direction, rising 1.56% on BSE and 1.94% on NSE — one of the better performers among smaller-cap names in the list.
Divi’s Laboratories, trading at ₹6,482.60 on BSE, was largely flat with a marginal gain of 0.11%. Torrent Pharma at ₹4,225.05 on BSE was also near flat, up 0.13%, while its NSE price at ₹4,217.90 showed a minor dip of 0.05%.
Broad Market Context
The Nifty 50 was trading at 24,105.95, up a marginal 0.05%, while the S&P BSE Sensex was at 77,265.41, down 0.05%. The flat-to-slightly-negative broad market tone is consistent with the mixed picture seen in the pharma sector this morning.
All price data in this article is sourced from early-session exchange feeds. BSE prices reflect the 9:31 AM IST snapshot; NSE prices reflect the 9:34–9:35 AM IST window. Intraday prices are subject to change.